These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 36438960)
1. Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy. Hersi H; Saarinen JT; Raitanen J; Peltola J Front Neurol; 2022; 13():1042168. PubMed ID: 36438960 [TBL] [Abstract][Full Text] [Related]
2. Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy. Hersi H; Raitanen J; Saarinen JT; Peltola J Epilepsia Open; 2023 Sep; 8(3):811-819. PubMed ID: 37010264 [TBL] [Abstract][Full Text] [Related]
3. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations. Moloney PB; Costello DJ Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361 [TBL] [Abstract][Full Text] [Related]
4. Starting a new anti-seizure medication in drug-resistant epilepsy: Add-on or substitute? Janmohamed M; Lawn N; Spilsbury K; Chan J; Dunne J Epilepsia; 2021 Jan; 62(1):228-237. PubMed ID: 33236785 [TBL] [Abstract][Full Text] [Related]
5. Earlier Age at Surgery for Brain Cavernous Angioma-Related Epilepsy May Achieve Complete Seizure Freedom without Aid of Anti-Seizure Medication. Fujimoto A; Enoki H; Hatano K; Sato K; Okanishi T Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326359 [TBL] [Abstract][Full Text] [Related]
6. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study. Hakeem H; Alsfouk BAA; Kwan P; Brodie MJ; Chen Z Epilepsia; 2023 May; 64(5):1248-1258. PubMed ID: 36869855 [TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England. Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576 [TBL] [Abstract][Full Text] [Related]
8. Response to first antiseizure medication in patients diagnosed with epilepsy. Hersi H; Saarinen JT; Raitanen J; Peltola J Acta Neurol Scand; 2021 Jul; 144(1):67-75. PubMed ID: 33835491 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road. Baheti N; Rathore C; Bansal AR; Shah S; Veedu HK; Prakash S; Kanhere K; Jaiswal SK; Jukkarwala A; Murthy JMK; Radhakrishnan K Seizure; 2021 Nov; 92():112-117. PubMed ID: 34496330 [TBL] [Abstract][Full Text] [Related]
17. Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy. Blank LJ; Agarwal P; Kwon CS; Boockvar K; Jetté N Epilepsia; 2024 Nov; 65(11):3216-3223. PubMed ID: 39340471 [TBL] [Abstract][Full Text] [Related]
18. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain. Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345 [TBL] [Abstract][Full Text] [Related]
19. Effect of clinical features on antiseizure medication doses in patients with newly diagnosed epilepsy. Hersi H; Peltola J; Raitanen J; Saarinen JT Front Neurol; 2023; 14():1159339. PubMed ID: 37609660 [TBL] [Abstract][Full Text] [Related]
20. Risk of recurrence in patients with an unprovoked tonic-clonic seizure and generalized epileptiform discharges on EEG. Jomaa N; Nasreddine W; Hmeimess G; Beaini S; Beydoun A; Hotait M; Wazne J; Beydoun A Epilepsia; 2023 Aug; 64(8):2153-2161. PubMed ID: 37264785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]